Current News Releases
Current News Releases
Rare in U.S. and elsewhere in the West, Behcet’s disease is concentrated in the Middle East
In a bid to improve awareness and care of a relatively rare disorder that inflames blood vessels throughout the body and damages organs, especially the eyes, a team of researchers led by a Johns Hopkins ophthalmologist has analyzed and published detailed information about 132 patients diagnosed and treated over 25 years in Saudi Arabia, where the disorder is not at all rare.
How can states and federal government provide adequate health care to poor people, without overburdening taxpayers or leaving health care providers with billions in unpaid bills? That thorny problem is especially challenging in the aftermath of a recession and congressional mandates expanding Medicaid eligibility.
Research results support calls for better player protections
A team of Johns Hopkins specialists, using a battery of imaging and cognitive tests, has gathered evidence of accumulated brain damage that could be linked to specific memory deficits in former National Football League (NFL) players experienced decades after they stopped playing the game.
Renowned Johns Hopkins Children’s Center pediatrician and former JAMA editor Catherine D. DeAngelis, M.D., M.P.H., will receive the 2015 Howland Medal of the American Pediatric Society, one of the highest awards in pediatric medicine, bestowed annually for distinguished service in the field as a whole.
Potential drug for pancreatic cancer now being tested in animals
Existing cancer therapies are geared toward massacring tumor cells, but Johns Hopkins researchers propose a different strategy: subtly hardening cancer cells to prevent them from invading new areas of the body. They devised a way of screening compounds for the desired effect and have identified a compound that shows promise in fighting pancreatic cancer.
Discovery in mice aids search for new therapies to stop “racing” heart rates
An animal study led by Johns Hopkins investigators has uncovered what controls the ability of healthy hearts to speed up in response to circumstances ranging from fear to a jog around the block.
New study suggests urban living may be overrated as risk factor for asthma
Challenging the long-standing belief that city dwellers suffer disproportionately from asthma, the results of a new Johns Hopkins Children’s Center study of more than 23,000 U.S. children reveal that income, race and ethnic origin may play far more potent roles in asthma risk than kids’ physical surroundings.
Unique boundary found for little-known cellular compartment
Organization is key to an efficient workplace, and cells are no exception to this rule. New evidence from Johns Hopkins researchers suggests that, in addition to membranes, cells have another way to keep their contents and activities separate: with ribbons of spinning proteins.
The flu season started earlier than usual this year, and most states are reporting continued and widespread outbreaks. Johns Hopkins emergency medicine and infectious disease experts are available to inform coverage of the ongoing flu epidemic.
Seasoned academic health system executive will lead the continued global expansion of Johns Hopkins Medicine
Pamela Paulk, M.S.W., M.B.A., has been named president of Johns Hopkins Medicine International, the division of Johns Hopkins Medicine that develops high-impact international health care collaborations and provides medical concierge services for patients who travel from other regions to receive care at Johns Hopkins. Paulk assumes the role on March 1.
The brains of some Iraq and Afghanistan combat veterans who survived blasts from improvised explosive devices (IEDs) and died later of other causes show a distinctive honeycomb pattern of broken and swollen nerve fibers throughout critical brain regions, including those that control executive function. The pattern is different from brain damage caused by car crashes, drug overdoses or collision sports, and may be the never-before-reported signature of blast injuries suffered by soldiers as far back as World War I
People hospitalized with certain rare blood cell disorders frequently receive a treatment that is associated with a two- to fivefold increase in death, according to a new study that reviewed hospital records nationwide. The study authors recommend that for these rare disorders, doctors should administer the treatment, a platelet transfusion, only in exceptional circumstances.
Mutations in a gene that helps repair damaged chromosome ends may make smokers — especially female smokers — more susceptible to emphysema, according to results of a new study led by Johns Hopkins Kimmel Cancer Center researchers.
Vernon Mountcastle, one of Johns Hopkins Medicine’s giants of the 20th century, died peacefully at his northern Baltimore home on Sunday, Jan. 11, with Nancy, his wife of seven decades, and family at his bedside. He was 96. Mountcastle was universally acknowledged as the “father of neuroscience” and served Johns Hopkins with extraordinary dedication for nearly 65 years.
A Roman philosopher was the first to note the relationship between a sound mind and a sound body. Now the findings of a new Johns Hopkins study reveal a possible biochemical explanation behind this ancient observation.
Levi Watkins remembers Maya Angelou: “It’s pretty heavy in here right now.” Event speakers emphasize tolerance.
For the 33rd consecutive year, the Johns Hopkins community gathered to celebrate the legacy and life’s work of Martin Luther King Jr.
Mouse study also suggests inability to burn fat in “brown fat” doesn’t lead to weight gain
In the race to find a safe and effective weight loss drug, much attention has focused on the chemical processes that store and use energy. But a new mouse study from Johns Hopkins suggests that tweaking these processes, even in a targeted way that affects only fat cells, may not yield a silver-bullet obesity cure.
Novel early physical therapy interventions in the intensive care unit sustained 5 years beyond inception via structured quality improvement process
In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement processes for delivering early physical rehabilitation in an intensive care unit (ICU) were sustained five years later — benefiting both patients and the health care facility.
Luring dormant HIV out of hiding and destroying its last cure-defying holdouts has become the holy grail of HIV eradication, but several recent attempts to do so have failed. Now the findings of a Johns Hopkins-led study reveal why that is and offer a strategy that could form a blueprint for a therapeutic vaccine to eradicate lingering virus from the body
Researchers at Johns Hopkins have found out how a protein crucial to learning works: by removing a biochemical “clamp” that prevents connections between nerve cells in the brain from growing stronger. The finding moves neuroscientists a step closer to figuring out how learning and memory work, and how problems with them can arise.